NDC 72266-159-01 - Ertapenem
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72266-159
- Requested NDC
- 72266-159-01
- Package NDCs from labels
- 72266-159-01, 72266-159-10, 72266-159-05
- Manufacturer
- Fosun Pharma USA Inc
- Effective date
- 2024-05-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ertapenem - Fosun Pharma USA Inc | Fosun Pharma USA Inc | 2024-05-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72266-159-01 | Ertapenem | 1 in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 1 | 6 | |
| 72266-159-05 | Ertapenem | 5 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 5 | 6 | |
| 72266-159-10 | Ertapenem | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72266-159-01 | EA - Each | 72266-159 | 56d38913-3987-4f31-9e38-ca32d6cc651d | 1 | 2021-12-08 |
| 72266-159-05 | EA - Each | 72266-159 | 14a74afe-f48b-45e4-873b-d8c8e18a2be3 | 1 | 2023-04-07 |
| 72266-159-10 | EA - Each | 72266-159 | cc203ca5-cab5-4a54-a433-65e8797d1c40 | 1 | 2021-12-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SODIUM BICARBONATE | SODIUM BICARBONATE | Richmond Pharmaceuticals, Inc. | fa10d93d-b3ed-4675-a117-f573d9e72bca | 2017-10-30 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Exela Pharma Sciences, LLC | e9698a4f-1a95-4f28-a945-e8009d1d6dd4 | 2017-09-27 | Warnings, Adverse reactions | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.